Unplanned readmission within 1 year after heart transplantation in Taiwan
Journal
Transplantation Proceedings
Journal Volume
42
Journal Issue
3
Pages
946-947
Date Issued
2010
Author(s)
Tsao C.-I.
Ko W.-J.
Abstract
Introduction Survival in patients with refractory heart failure greatly improves after heart transplantation (HTx). Objective To evaluate the rate of unplanned readmission within the first year post-HTx and the causes of such readmission. Patients and Methods From January 2005 to June 2008, the 112 patients who underwent HTx were regularly followed up at our hospital. A protocol biopsy was performed every week during the first month, then every 3 months during the first year. Any unplanned readmission was discussed in detail in a transplantation meeting. Data were collected from review of medical records. Results The rate of unplanned readmission was 19.3% in 2005, 21.5% in 2006, 22.2% in 2007, and 20.3% in 2008. Infection was the primary cause leading to unplanned readmission in 2005 (51.5%), 2006 (42.9%), and 2008 (30.7%). Rejection was the primary cause leading to readmission in 2007 (40%). Other causes included fluid retention, pericardial effusion, anemia, and systemic diseases. Conclusion To reduce unplanned readmissions and to promote quality of life and long-term survival, health professionals must meticulously monitor the adverse effects of treatments including immunosuppression agents and concomitantly used medications. ? 2010 Elsevier Inc.
SDGs
Other Subjects
basiliximab; cyclosporin; hybrid protein; immunosuppressive agent; lymphocyte antibody; monoclonal antibody; tacrolimus; article; biopsy; follow up; graft rejection; heart transplantation; hospital readmission; human; immunology; pathology; patient care planning; pericardial effusion; retrospective study; statistics; Taiwan; time; Antibodies, Monoclonal; Antilymphocyte Serum; Biopsy; Cyclosporine; Follow-Up Studies; Graft Rejection; Heart Transplantation; Humans; Immunosuppressive Agents; Patient Care Planning; Patient Readmission; Pericardial Effusion; Recombinant Fusion Proteins; Retrospective Studies; Tacrolimus; Taiwan; Time Factors
Type
conference paper